Tuberculosis Testing was the most widespread disease in the world between the 1950s and 1960s and the World Health Organization (WHO) declared it as a global emergency in 1993. The increase in the incidence of tuberculosis over the years has been accompanied by the spread of HIV/AIDS and the emergence of multidrug-resistant strains of tuberculosis. The number of new cases of tuberculosis began to rise in the U.S. in the mid-1980s. The number grew further by about 14% from 1985 to 1993. According to the WHO, 1.5 million people died from tuberculosis across the globe in 2013.
Tuberculosis Testing is still highly prevalent in many parts of the world and is continuing to affect millions of lives, especially in the regions of Africa and Asia. Over the years, the TB pathogen has advanced and taken a more intense and potent form commonly referred to as ‘extensively drug resistant’ (XDR) TB.
As the prevalence of TB is high and increasing at a rapid rate, the need for more extensive diagnostic and treatment measures to check its spread has increased globally. The high number of TB cases have also led to increased acceptance of various TB testing techniques and procedures that help in early diagnosis of the disease, ensuring proper treatment of the TB-affected patient population. Rapid acceptance of expensive but improved TB tests and increasing purchasing power among individuals is boosting the market. Overall, the market is expected to reach US$2,619.4 million by 2020, at a moderate CAGR of 4.3% from 2014 to 2020.
Government Health Programs: Drive for Tuberculosis Elimination
Over the years, various governments and private organizations have taken many initiatives to promote awareness about tuberculosis and treat the condition with appropriate testing methods such as chest x-rays, culture tests, tuberculin skin tests, smear microscopy, and nucleic acid amplification tests available in the market.
The Centers for Disease Control and Prevention (CDC), through the Global Laboratory Activity and Division of Tuberculosis Elimination’s International Research and Programs Branch, works to improve the quality of the control programs. Through their effective laboratory procedures and clinical/operational research, CDC helps evaluate promising diagnostic and treatment strategies in the global market. These control programs operate internationally to promote awareness about TB and TB tests.
In order to conduct effective TB control activities, TB control programs across the globe have provided proper guidance to facilities and practitioners involved in TB control activities. The programs are based on an overall TB control strategy that includes procedures and policies to ensure the appropriate laws are available to support tuberculosis control activities.
Moreover, TB control health programs are usually in collaboration with professional societies, local health care providers, and voluntary organizations. Increased funds from state, local, federal, and private sources for TB control activities have fueled the market for tuberculosis testing.